Artikel dengan mandat akses publik - Ying WanPelajari lebih lanjut
Tersedia di suatu tempat: 5
Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the NanopatchTM Microneedle …
Y Wan, V Gupta, C Bird, SR Pullagurla, P Fahey, A Forster, DB Volkin, ...
Human vaccines & immunotherapeutics 17 (8), 2501-2516, 2021
Mandat: Bill & Melinda Gates Foundation
Genetic dissection of Arabidopsis MAP kinase phosphatase 1-dependent PAMP-induced transcriptional responses
L Jiang, Y Wan, JC Anderson, J Hou, SM Islam, J Cheng, SC Peck
Journal of experimental botany 68 (18), 5207-5220, 2017
Mandat: US National Science Foundation
Analytical and preformulation characterization studies of human papillomavirus virus-like particles to enable quadrivalent multi-dose vaccine formulation development
K Jerajani, Y Wan, JM Hickey, OS Kumru, N Sharma, SR Pullagurla, ...
Journal of Pharmaceutical Sciences 111 (11), 2983-2997, 2022
Mandat: Bill & Melinda Gates Foundation
Multi-dose formulation development for a quadrivalent human papillomavirus virus-like particle-based vaccine: part I-screening of preservative combinations
K Jerajani, Y Wan, OS Kumru, SR Pullagurla, P Kumar, N Sharma, ...
Journal of Pharmaceutical Sciences 112 (2), 446-457, 2023
Mandat: Bill & Melinda Gates Foundation
Multi-dose formulation development for a quadrivalent human papillomavirus virus-like particle-based vaccine: part II-Real-time and accelerated stability studies
N Sharma, K Jerajani, Y Wan, OS Kumru, SR Pullagurla, O Ogun, ...
Journal of Pharmaceutical Sciences 112 (2), 458-470, 2023
Mandat: Bill & Melinda Gates Foundation
Informasi terbitan dan pendanaan ditentukan secara otomatis oleh program komputer